These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
667 related items for PubMed ID: 26700832
21. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease. Pandya A, Sy S, Cho S, Weinstein MC, Gaziano TA. JAMA; 2015 Jul 14; 314(2):142-50. PubMed ID: 26172894 [Abstract] [Full Text] [Related]
22. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey. Gupta K, Kakar TS, Jain V, Gupta M, Al Rifai M, Slipczuk L, Nambi V, Bittner V, Blumenthal RS, Stone NJ, Lavie CJ, Virani SS. Prog Cardiovasc Dis; 2022 Jul 14; 75():78-82. PubMed ID: 36038004 [Abstract] [Full Text] [Related]
23. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study. Hamoui O, Omar MI, Raal FJ, Rashed W, Kane A, Alami M, Abreu P, Mashhoud W, Alsheikh-Ali AA. BMC Cardiovasc Disord; 2019 Mar 15; 19(1):61. PubMed ID: 30876390 [Abstract] [Full Text] [Related]
24. In primary prevention, the ACC/AHA risk-based approach predicted ASCVD better than trial-based or hybrid approaches. Blaha M. Ann Intern Med; 2016 Apr 19; 164(8):JC47. PubMed ID: 27089097 [No Abstract] [Full Text] [Related]
25. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients. Okerson T, Patel J, DiMario S, Burton T, Seare J, Harrison DJ. J Am Heart Assoc; 2017 Mar 17; 6(3):. PubMed ID: 28314797 [Abstract] [Full Text] [Related]
26. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Wilson PWF, Polonsky TS, Miedema MD, Khera A, Kosinski AS, Kuvin JT. J Am Coll Cardiol; 2019 Jun 25; 73(24):3210-3227. PubMed ID: 30423394 [Abstract] [Full Text] [Related]
27. Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA). Flueckiger P, Qureshi W, Michos ED, Blaha M, Burke G, Sandfort V, Herrington D, Yeboah J. Clin Cardiol; 2017 Mar 25; 40(3):163-169. PubMed ID: 27859433 [Abstract] [Full Text] [Related]
28. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses. Garg N, Muduli SK, Kapoor A, Tewari S, Kumar S, Khanna R, Goel PK. Indian Heart J; 2017 Mar 25; 69(4):458-463. PubMed ID: 28822511 [Abstract] [Full Text] [Related]
29. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. Maddox TM, Borden WB, Tang F, Virani SS, Oetgen WJ, Mullen JB, Chan PS, Casale PN, Douglas PS, Masoudi FA, Farmer SA, Rumsfeld JS. J Am Coll Cardiol; 2014 Dec 02; 64(21):2183-92. PubMed ID: 25447259 [Abstract] [Full Text] [Related]
30. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease. Karmali KN, Goff DC, Ning H, Lloyd-Jones DM. J Am Coll Cardiol; 2014 Sep 09; 64(10):959-68. PubMed ID: 25190228 [Abstract] [Full Text] [Related]
31. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations. Zupec JF, Marrs JC, Saseen JJ. Ann Pharmacother; 2016 Jan 09; 50(1):17-21. PubMed ID: 26416950 [Abstract] [Full Text] [Related]
32. Guidelines versus trial-evidence for statin use in primary prevention: The Copenhagen General Population Study. Mortensen MB, Nordestgaard BG. Atherosclerosis; 2022 Jan 09; 341():20-26. PubMed ID: 34959205 [Abstract] [Full Text] [Related]
33. Hyperlipidemia: Drugs for Cardiovascular Risk Reduction in Adults. Last AR, Ference JD, Menzel ER. Am Fam Physician; 2017 Jan 15; 95(2):78-87. PubMed ID: 28084704 [Abstract] [Full Text] [Related]
34. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines. Marston NA, Bonaca MP, Jarolim P, Goodrich EL, Bhatt DL, Steg PG, Cohen M, Storey RF, Johanson P, Wiviott SD, Braunwald E, Sabatine MS, Morrow DA. JAMA Cardiol; 2020 Nov 01; 5(11):1255-1262. PubMed ID: 32756916 [Abstract] [Full Text] [Related]
36. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers. Akhabue E, Rittner SS, Carroll JE, Crawford PM, Dant L, Laws R, Leo MC, Puro J, Persell SD. J Am Heart Assoc; 2017 Jul 03; 6(7):. PubMed ID: 28673901 [Abstract] [Full Text] [Related]
40. Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis. Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, Garcia-Colunga JI, Arvizu-Rivera RI, Martinez-Moreno A, Villarreal-Perez JZ, Elizondo-Riojas G, Garza Elizondo MA. Clin Rheumatol; 2016 Nov 03; 35(11):2823-2827. PubMed ID: 27222044 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]